Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

16 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Safety and anti-HCV effect of prolonged intravenous silibinin in HCV genotype 1 subjects in the immediate liver transplant period.
Bárcena R, Moreno A, Rodríguez-Gandía MA, Albillos A, Arocena C, Blesa C, García-Hoz F, Graus J, Nuño J, López-Hervás P, Gajate L, Martínez A, Bermejo T, Mateos ML, Del Campo S; Hospital Ramón y Cajal Liver Transplant Group. Bárcena R, et al. Among authors: blesa c. J Hepatol. 2013 Mar;58(3):421-6. doi: 10.1016/j.jhep.2012.10.009. Epub 2012 Oct 13. J Hepatol. 2013. PMID: 23073223
HCV clearance and treatment outcome in genotype 1 HCV-monoinfected, HIV-coinfected and liver transplanted patients on peg-IFN-alpha-2b/ribavirin.
Moreno A, Bárcena R, García-Garzón S, Muriel A, Quereda C, Moreno L, Mateos ML, Fortún J, Martín-Dávila P, García M, Blesa C, Otón E, Moreno A, Moreno S. Moreno A, et al. Among authors: blesa c. J Hepatol. 2005 Nov;43(5):783-90. doi: 10.1016/j.jhep.2005.05.019. Epub 2005 Jun 21. J Hepatol. 2005. PMID: 16084622
Partial splenic embolization and peg-IFN plus RBV in liver transplanted patients with hepatitis C recurrence: safety, efficacy and long-term outcome.
Bárcena R, Moreno A, Foruny JR, Blázquez J, Graus J, Riesco JM, Blesa C, García-Hoz F, Sánchez J, Gil-Grande L, Nuño J, Fortún J, Rodriguez-Sagrado MA, Moreno A. Bárcena R, et al. Among authors: blesa c. Clin Transplant. 2010 May-Jun;24(3):366-74. doi: 10.1111/j.1399-0012.2009.01081.x. Epub 2009 Oct 22. Clin Transplant. 2010. PMID: 19863593
Hepatitis C recurrence after liver transplantation: Viral and histologic response to full-dose PEG-interferon and ribavirin.
Oton E, Barcena R, Moreno-Planas JM, Cuervas-Mons V, Moreno-Zamora A, Barrios C, Garcia-Garzon S, Moreno A, Boullosa-Graña E, Rubio-Gonzalez EE, Garcia-Gonzalez M, Blesa C, Mateos ML. Oton E, et al. Among authors: blesa c. Am J Transplant. 2006 Oct;6(10):2348-55. doi: 10.1111/j.1600-6143.2006.01470.x. Epub 2006 Jul 26. Am J Transplant. 2006. PMID: 16869810 Free article.
Initial immunosuppression with or without basiliximab: a comparative study.
Martín-Mateos RM, Graus J, Albillos A, Arocena C, Rodríguez Gandía MA, Blesa C, García-Hoz F, García González M, García-Alonso FJ, Bárcena R. Martín-Mateos RM, et al. Among authors: blesa c. Transplant Proc. 2012 Nov;44(9):2570-2. doi: 10.1016/j.transproceed.2012.09.109. Transplant Proc. 2012. PMID: 23146457
16 results